Hurry while stocks last could be the description at ValiRx (VAL), a life science company. It announced that it wishes to provide investors who did not participate in the Fundraising
Hurry while stocks last could be the description at ValiRx (VAL), a life science company. It announced that it wishes to provide investors who did not participate in the Fundraising
In last week’s Week In Small Caps, I suggested that we may have reached “Peak Doom”. Therefore it was rather pleasant that Thursday saw a 1,200 rise on the Dow,
Chaarat (CGH), the AIM-quoted gold mining company, announced the updated JORC Compliant Mineral Resource Estimate for its Kapan polymetallic mine in the Republic of Armenia.
Chaarat (AIM:CGH), the AIM-quoted gold mining Company with an operating mine in Armenia, and assets at various stages of development in the Kyrgyz Republic is pleased to announce the updated JORC Compliant Mineral
Greatland Gold (GGP), a mining development and exploration company, provided an exploration and development update at the Havieron gold-copper project in the Paterson region of Western Australia.
Chaarat (AIM:CGH), the AIM-quoted gold mining company with assets in the Kyrgyz Republic and Armenia, notes recent media speculation and confirms that it is in discussions regarding the potential acquisition
This week we were reminded that in politics there are certain rules to follow: never do what you said you would do – especially when it would help the electorate.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Baron Oil, Bezant Resources,
The newsflow appears to be accelerating at Chaarat Gold (CGH), the AIM-quoted gold mining company with an operating mine in Armenia, and assets at various stages of development in the
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Pound / Dollar, Bitcoin,
Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, announced that Chief Executive Officer, Jeremy Skillington, has purchased 718,733 shares at 4.78p.